Administrative Core
行政核心
基本信息
- 批准号:10469446
- 负责人:
- 金额:$ 57.06万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-08-15 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:AdoptedAdoptionAdvocateAlzheimer&aposs DiseaseAnimal WelfareBiological MarkersCaregiversChicagoCitiesClinical TrialsCollaborationsContractsDataDementiaDevelopmentEducationEnsureFacultyFundingGoalsHealth Insurance Portability and Accountability ActIllinoisInstitutional Review BoardsLeadLeadershipMonitorParentsPatientsPoliciesProgress ReportsResearchResearch PriorityResource SharingResourcesRoleRunningSamplingTimeTranslational ResearchUnited States National Institutes of HealthUniversitiesUpdatebeneficiarycohesionhuman subjectinnovationmeetingsmolecular imagingoperationranpirnaserecruitresponsible research conduct
项目摘要
PROJECT SUMMARY - ADMINISTRATIVE CORE
The ultimate goal of an Alzheimer's Disease Research Center (ADRC) is to promote innovative research on
dementia and its treatments while ensuring that patients and caregivers become the beneficiaries of resultant
advances. An effective Administrative Core is essential for transforming these goals into accomplishments. To
this end, the Administrative Core of the Northwestern ADRC will be guided by the following goals:
1) Lead the day-to-day running of the ADRC and promote "centerness" so that ADRC components function
cohesively and leverage dementia-related activities throughout Northwestern University.
2) Maximize the utilization of ADRC resources to fit local and national priorities.
3) Coordinate the adoption of UDS-3, the FTLD module, new clinical trials, and the increased emphasis on
biomarkers, including structural and molecular imaging.
4) Facilitate interactions with NACC, NCRAD, and national consortia such as ADNI and ADCS, the
Alzheimer's Association, and relevant agencies within the City of Chicago and State of Illinois.
5) Encourage innovative Development Projects, coordinate their review, and monitor the progress of those
that receive ADRC funding.
To fulfill these goals, the Administrative Core will oversee the finances of the parent NIA P30 and of additional
contracts related to multi-center collaborations and clinical trials. It will be responsible for timely progress
reports related to these activities as well as the organization of the yearly Scientific Advisory Board (SAB)
meeting. An equally important role will be to ensure that the ADRC as a whole meets all IRB and HIPAA
requirements and that it is in compliance with NIH policies for human subjects, animal welfare, scientific
integrity, data and sample sharing and financial policy. The Administrative Core is also responsible for
coordinating the interactions of the ADRC with NIA, other NIH components, other ADRCs, and relevant
agencies at the national, state and local levels. Within Northwestern University, the Administrative Core will
advocate the allocation of additional faculty, space and financial resources to dementia research.
项目总结--行政核心
阿尔茨海默病研究中心(ADRC)的最终目标是促进对
痴呆症及其治疗,同时确保患者和照顾者成为结果的受益者
预付款。有效的行政核心对于将这些目标转化为成就至关重要。至
为此,西北ADRC的行政核心将以以下目标为指导:
1)领导ADRC的日常运行,促进“中心化”,使ADRC组件发挥作用
在整个西北大学内凝聚和利用与痴呆症相关的活动。
2)最大限度地利用红十字国际委员会的资源,以适应地方和国家的优先事项。
3)协调采用UDS-3、FTLD模块、新的临床试验,并更加重视
生物标志物,包括结构和分子成像。
4)促进与NACC、NCRAD以及ADNI和ADCS等国家财团的互动,
阿尔茨海默氏症协会,以及芝加哥和伊利诺伊州内的相关机构。
5)鼓励创新发展项目,协调其审查,并监测其进展情况
接受ADRC资助的公司。
为了实现这些目标,行政核心将监督母公司NIA P30和其他
与多中心合作和临床试验相关的合同。它将负责及时取得进展
与这些活动有关的报告以及年度科学咨询委员会的组织情况
开会。同样重要的作用将是确保亚洲发展委员会作为一个整体符合所有IRB和HIPAA
它符合美国国立卫生研究院关于人类受试者、动物福利、科学
诚信、数据和样本共享以及财务政策。行政核心还负责
协调ADRC与NIA、NIH其他部门、其他ADRC和相关机构的互动
国家、州和地方各级的机构。在西北大学内部,行政核心将
倡导为痴呆症研究分配更多的师资、空间和财政资源。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROBERT J VASSAR其他文献
ROBERT J VASSAR的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROBERT J VASSAR', 18)}}的其他基金
Mechanisms of Angiotensin I Converting Enzyme in Alzheimer's disease
血管紧张素I转换酶在阿尔茨海默病中的作用机制
- 批准号:
10568226 - 财政年份:2022
- 资助金额:
$ 57.06万 - 项目类别:
NORTHWESTERN Alzheimer's Disease Research Center
西北阿尔茨海默病研究中心
- 批准号:
10469445 - 财政年份:2021
- 资助金额:
$ 57.06万 - 项目类别:
NORTHWESTERN Alzheimer's Disease Research Center
西北阿尔茨海默病研究中心
- 批准号:
10264367 - 财政年份:2021
- 资助金额:
$ 57.06万 - 项目类别:
NORTHWESTERN Alzheimer's Disease Research Center
西北阿尔茨海默病研究中心
- 批准号:
10662473 - 财政年份:2021
- 资助金额:
$ 57.06万 - 项目类别:
Northwestern ADRC Non competing supplement application
西北 ADRC 非竞争性补充申请
- 批准号:
10577047 - 财政年份:2021
- 资助金额:
$ 57.06万 - 项目类别:
The Role of RNA Binding Protein Networks in Tauopathy and Related Dementia
RNA 结合蛋白网络在 Tau 病和相关痴呆中的作用
- 批准号:
10034785 - 财政年份:2020
- 资助金额:
$ 57.06万 - 项目类别:
2nd Kloster Seeon Meeting on BACE Proteases in Health and Disease
关于 BACE 蛋白酶在健康和疾病中的作用的第二届 Kloster Seeon 会议
- 批准号:
9195559 - 财政年份:2016
- 资助金额:
$ 57.06万 - 项目类别:
Molecular Neuropathology and Mechanisms of BACE1 Elevation in Alzheimer's Disease
阿尔茨海默氏病 BACE1 升高的分子神经病理学和机制
- 批准号:
7248235 - 财政年份:2007
- 资助金额:
$ 57.06万 - 项目类别:
相似海外基金
WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
- 批准号:
10093543 - 财政年份:2024
- 资助金额:
$ 57.06万 - 项目类别:
Collaborative R&D
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
- 批准号:
24K16436 - 财政年份:2024
- 资助金额:
$ 57.06万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
- 批准号:
24K16488 - 财政年份:2024
- 资助金额:
$ 57.06万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 57.06万 - 项目类别:
EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
- 批准号:
24K20973 - 财政年份:2024
- 资助金额:
$ 57.06万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 57.06万 - 项目类别:
EU-Funded
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
- 批准号:
10075502 - 财政年份:2023
- 资助金额:
$ 57.06万 - 项目类别:
Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
- 批准号:
10089082 - 财政年份:2023
- 资助金额:
$ 57.06万 - 项目类别:
EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
- 批准号:
481560 - 财政年份:2023
- 资助金额:
$ 57.06万 - 项目类别:
Operating Grants
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
- 批准号:
2321091 - 财政年份:2023
- 资助金额:
$ 57.06万 - 项目类别:
Standard Grant